Accretion Nutraveda (ANL) Share Price rises 8.23% to Rs 292

Accretion Nutraveda Share Price is trading at Rs 292, up 8.23% today, with market capitalisation at Rs 195.34 Cr. The move puts Accretion Nutraveda Ltd. in focus in Healthcare as investors track Accretion Nutraveda Share Price Today, Accretion Nutraveda Stock News and the latest Accretion Nutraveda Share Price update. Univest data confirms the move itself, though no company-specific trigger has been identified. That makes the price rise a clean market event rather than a story built on speculation. The key question for readers is not only what Accretion Nutraveda Share Price did today, but how the valuation, profitability ratios and sector comparison frame the move.

The stock is trading at the same level as the day open, day high and day low, which keeps the discussion tightly anchored to price action rather than intraday narrative. Univest also shows the company’s fundamentals alongside listed Healthcare peers, helping investors assess whether the latest Accretion Nutraveda Share Price strength sits comfortably within its own operating profile.

Accretion Nutraveda Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 292
Previous Close	Rs 269.8
Today's Move	Rs 22.2 (+8.23%)
Open	Rs 292
High	Rs 292
Low	Rs 292
Market Capitalisation	Rs 195.34 crore
Market Cap Category	Micro Cap

Accretion Nutraveda Ltd. (ANL) rose to Rs 292 from the previous close of Rs 269.8, a move of Rs 22.2 or 8.23%. The stock opened at Rs 292, reached a high of Rs 292, recorded a low of Rs 292.

Accretion Nutraveda Share Price is trading higher by Rs 22.20 from the previous close, and the stock is at Rs 292 after a 8.23% rise. The opening level, day high and day low are all Rs 292, so the move is concentrated at a single price point in today’s trade. That is the core price action story behind Accretion Nutraveda Share Price Today.

For readers tracking Accretion Nutraveda Share Price Live, the immediate reference points are clear: previous close at Rs 269.8, current price at Rs 292, and market capitalisation at Rs 195.34 Cr. Accretion Nutraveda Share News is therefore centred on a firm intraday gain rather than a broader price range. Univest data confirms the rise, while no company-specific catalyst is established. This is why the stock appears in market updates and top gainer conversations even without a narrative trigger. The next layer is the company’s fundamental profile, which helps put the share price rise into context.

Accretion Nutraveda Ltd. (ANL) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 195.34 crore
P/E Ratio	38.54x
P/B Ratio	6.19x
ROE	27.68%
ROCE	30.19%
EPS	Rs 7
Book Value Per Share	Rs 43.6
Dividend Yield	0%

Accretion Nutraveda Ltd. (ANL) fundamental metrics show P/E 38.54x, P/B 6.19x, ROE 27.68%, ROCE 30.19%. Read together, these ratios describe the company's position rather than a recommendation.

Accretion Nutraveda Ltd. has a market capitalisation of Rs 195.34 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 38.54x, P/B at 6.19x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 27.68% and ROCE of 30.19%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 7, book value per share of Rs 43.6, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.59x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	38.54x
Benchmark Median P/E	32.59x
Benchmark Average P/E	49x
Benchmark P/E Range	3.46x to 707.31x
Company P/B Ratio	6.19x
Benchmark Median P/B	2.88x
Company ROE	27.68%
Benchmark Median ROE	11.7%
Company ROCE	30.19%
Benchmark Median ROCE	13.61%
Company Market Capitalisation	Rs 195.34 crore
Benchmark Median Market Cap	Rs 783.26 crore

Accretion Nutraveda Ltd. (ANL) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Accretion Nutraveda Ltd. (ANL) has a P/E ratio of 38.54x, which is above the benchmark median of 32.59x, a difference of +18.26%. The P/E comparison frames valuation; it is not a signal to buy or sell.

Accretion Nutraveda Ltd. (ANL) has a ROE of 27.68%, which is above the benchmark median of 11.7%, a difference of +136.58%. Accretion Nutraveda Ltd. (ANL) has a ROCE of 30.19%, which is above the benchmark median of 13.61%, a difference of +121.82%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,44,716.74	36.5	5.1	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,55,115.31	86.51	14.33	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,89,613.38	84.92	20.64	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,19,899.96	26.79	4.48	19.69	21.39
Cipla Ltd.	CIPLA	1,12,875.68	33.29	3.19	11.83	16

Accretion Nutraveda Ltd. (ANL) has a P/E ratio of 38.54x compared with the displayed peer median of 36.5x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 27.68% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 30.19% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Accretion Nutraveda Ltd. (ANL) has a market capitalisation of Rs 195.34 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Accretion Nutraveda

• Accretion Nutraveda Share Price is up 8.23% today, so the price action itself is drawing attention in Stock Market Today coverage.
• The stock is trading at Rs 292, with the same level as the day open, high and low, which keeps the move easy to track in Share Market Today updates.
• Accretion Nutraveda Share Price Today is supported by ROE of 27.68% and ROCE of 30.19%, both above the Healthcare benchmark.
• The company’s P/E of 38.54 and P/B of 6.19 sit above industry medians, so valuation remains central to Accretion Nutraveda Stock News.
• Its market cap of Rs 195.34 Cr makes it smaller than major listed peers, which is useful context for Accretion Nutraveda Share Price rise analysis.

About Accretion Nutraveda

Accretion Nutraveda Ltd. operates in Healthcare and is classified under Pharmaceuticals & Drugs. For readers following Accretion Nutraveda Share Price, the business context matters because sector positioning shapes how the market reads valuation and return ratios. The company is part of an industry where peer comparison often highlights differences in scale, margin structure and capital efficiency.

Accretion Nutraveda Share Price Today is therefore best viewed through its listed financial ratios and industry standing rather than broad corporate claims. The company’s market capitalisation is Rs 195.34 Cr, and the latest Univest figures show strong ROE and ROCE relative to the industry benchmark. That combination places Accretion Nutraveda Stock News in the broader conversation around Healthcare stock performance, where investors often compare smaller companies with larger listed peers to judge valuation and quality on the same frame. The company remains a useful watchlist name for anyone tracking Accretion Nutraveda Share Price Update, fundamental analysis and market cap context.

Frequently Asked Questions

Why is Accretion Nutraveda Share Price rising today?

Ans. Accretion Nutraveda Share Price is rising today by 8.23% to Rs 292. Univest data confirms the move itself, though no company-specific trigger has been identified. The previous close was Rs 269.8.

What is Accretion Nutraveda Share Price today?

Ans. Accretion Nutraveda Share Price is Rs 292 as of 29 September 2026 at 3:22:47 PM IST. It is up from the previous close of Rs 269.8. The stock moved 8.23% so far today.

How much did Accretion Nutraveda Share Price change today?

Ans. Accretion Nutraveda Share Price rose by Rs 22.20, which works out to 8.23%. The current price, previous close and day change all point to a clear intraday gain.

What is the market capitalisation of Accretion Nutraveda?

Ans. Accretion Nutraveda Share Price today comes with a market capitalisation of Rs 195.34 Cr. That places the company well below the industry median market cap of Rs 783.26 Cr.

What is Accretion Nutraveda Share Price valuation?

Ans. Accretion Nutraveda Share Price trades at a P/E of 38.54 and a P/B of 6.19. Both are above the Healthcare industry median, so valuation remains important. The previous close was Rs 269.8.

How do Accretion Nutraveda returns compare with peers?

Ans. Accretion Nutraveda Share Price is supported by ROE of 27.68% and ROCE of 30.19%. Those ratios compare favourably with several listed Healthcare peers in the same industry set.

What does Accretion Nutraveda EPS and book value show?

Ans. Accretion Nutraveda Share Price is backed by EPS of 7 and book value of Rs 43.6. EPS reflects earnings per share, while book value shows accounting net worth per share.

Should investors track Accretion Nutraveda Share Price today?

Ans. Accretion Nutraveda Share Price is worth tracking because the stock has risen today, carries strong return ratios and trades above key Healthcare valuation medians. Univest keeps these figures easy to monitor.

Track Accretion Nutraveda Share Price on Univest

Use Accretion Nutraveda Ltd. (ANL) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Univest tracks Accretion Nutraveda Share Price, Accretion Nutraveda Share Price Today, valuation ratios, 52-week levels and company insights in one place. Readers can follow Accretion Nutraveda Stock Analysis, sector comparisons and Accretion Nutraveda Latest News without losing sight of the live price. If the share price rise continues to matter through the day, Univest keeps the price action and fundamentals in the same view.